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Introduction
Metastatic hepatocellular carcinoma (HCC) to the perito-
neum is rare [1]. While microwave ablation (MWA) has an 
established role for the treatment HCC, its role for extrahe-
patic disease is less defined [2,3]. For tumours located on the 
surface of the liver this case demonstrates a successful use of 
MWA to treat an unusual manifestation of metastatic HCC. 
Hydrodissection is typically used to protect adjacent organs 
from thermal injury during ablation [4]. 
Case description
A 79-year-old man with a history of hepatitis B infec-
tion underwent laparoscopic left hepatectomy for a bi-
opsy-proven 6.5-cm HCC. Four years later, surveillance 
magnetic resonance imaging (MRI) revealed a 1.2-cm 
enhancing nodule; it was unclear from imaging whether 
the nodule was a surface implant or in the periphery of 
segment V (Figure 1). The patient was initially referred 
for surgical resection, but both the surgeon and patient 
were hesitant to embark on repeat operation. Therefore, 
the patient was referred to Interventional Radiology for 
percutaneous locoregional therapy. Ablative options of 
radiofrequency ablation, MWA, cryoablation, and irre-
versible electroporation were all considered. Ultimately, 
computed tomography (CT)-guided MWA was chosen 
based on the anticipated short ablation time.
Hydrodissection was performed in order to displace 
the liver edge from the peritoneal surface, in order to 
minimise thermal injury to the peritoneum. Using (CT) 
guidance, a 19-gauge Chiba needle was advanced into the 
peritoneal space, and 360 ml of diluted contrast material 
Figure 1. Gadolinium-enhanced MRI demonstrating an enhanced nodule 
on the periphery of the right hepatic lobe (white arrow)
Figure 2. After hydrodissection, the nodule was identified as a peritoneal 
implant (white arrow). Black asterisk indicates hydrodissection fluid
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Figure 3. Axial CT image demonstrating microwave antenna (white ar-
row) in the peritoneal nodule. Microwave ablation was performed utilising 
40 W × 3 minutes
Figure 4. Gadolinium-enhanced T1-fat saturated MRI of the liver obtained 
one-month post MWA of peritoneal nodule. White arrow shows ablated 
area with no evidence of residual disease
(20 cc Ultravist diluted in 1000 cc of 0.9% NS) was inject-
ed. This revealed that the nodule was a peritoneal deposit 
(Figure 2). Subsequently, CT-guided MWA of the perito-
neal nodule was performed using 40 watts for three min-
utes (Figure 3). An immediate post-ablation CT demon-
strated a decrease in size of the lesion without immediate 
complication. A gadolinium-enhanced MRI obtained one 
month later showed no evidence of residual disease or 
peritoneal fluid accumulation (Figure 4).
Conclusions
In this case, hydrodissection served not only to displace 
the liver away from the peritoneum but also functioned 
as a diagnostic tool to clearly define the nodule location 
as a peritoneal implant. As described in this paper, MWA 
could be a safe and technically effective method in the 
management of peritoneal seeding; however, addition-
al studies are necessary to explore the potential value of 
MWA for extra-hepatic disease for HCC.
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